Hollingsworth J, Wu S, Adkoli A, Farrell A, Hodges K, Oberley M, Karnezis A, Thaker P, Girda E. Molecular characterization of squamous cell ovarian cancers for identification of therapeutic targets. Gynecologic Oncology, Volume 190, Supplement 1, 2024, Pages S151-S152, ISSN 0090-8258, https://doi.org/10.1016/j.ygyno.2024.07.223.
Graves S, Sullivan MW, Adkoli A, Zhou Q, Iasonos A, Selenica P, Aghajanian C, Liu YL, Tew W, Sonoda Y, Ellenson LH, Chi D, O'Cearbhaill RE, Weigelt B, Grisham RN. Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer. Gynecol Oncol. 2024 Dec 7;192:120-127. doi: 10.1016/j.ygyno.2024.11.011. PMID: 39647188.
Sullivan MW, Graves S, Adkoli A, Zhou Q, Iasonos A, Ellenson LH, Chi DS, Aghajanian C, Liu YL, Sonoda Y, O'Cearbhaill RE, Weigelt B, Grisham RN. Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer. Cancer. 2024 Aug 16. doi: 10.1002/cncr.35523. PMID: 39150003.
Adkoli A, Vera K, Glennan P, Acuna Villaorduna A, Yeung K, Girda E, Goel. Participation of patients with gynecological cancer in phase 1 clinical trials: Experience from 2 NCI-Designated Comprehensive Cancer Centers.. JCO 42, e17610-e17610(2024). DOI:10.1200/JCO.2024.42.16_suppl.e17610
Adkoli A, Tomita-Barber J, Patel A, Liu N, Greenberg P, Girda E, Patankar S. Trends in palliative care utilization among patients with ovarian cancer in the United States.. JCO 42, e24083-e24083(2024). DOI:10.1200/JCO.2024.42.16_suppl.e24083
Hollingsworth J, Wu S, Adkoli A, Farrell A, Hodges K, Oberley M, Karnezis A, Thaker P, Girda E. Molecular and immune characterization of squamous cell ovarian cancers for identification of therapeutic targets. JCO 42, 5584-5584(2024). DOI:10.1200/JCO.2024.42.16_suppl.5584
Adkoli A, Eng S, Stephenson R. Need For Formalized Robotic Training and Curriculum in Obstetrics and Gynecology Residency: An Examination of Current Resident Outlooks and Perspectives. Journal of Robotic Surgery. 2024 May 21;18(1):218. doi: 10.1007/s11701-024-01985-9. PMID: 38771400; PMCID: PMC11108913.
Adkoli A, Alcorta Proano R, Girda E. Completed durable response of advanced endometrial cancer treated with pembrolizumab without surgical intervention or systemic chemotherapy: A case report. Current Problems in Cancer: Case Reports, Volume 14, 2024, 100285, ISSN 2666-6219, https://doi.org/10.1016/j.cpccr.2024.100285.
Adkoli A, Smith C, Kennedy T, et al. (February 12, 2024) A Report of a Rare Case of Rapidly Progressing Immature Teratoma With Associated Splenic Metastasis and Gliomatosis Peritonei. Cureus 16(2): e54080. doi:10.7759/cureus.54080
Adkoli A, Kumar S, Futterman I D, et al. (July 16, 2022) Access to Family Planning Services Following Natural Disasters and Pandemics: A Review of the English Literature. Cureus 14(7): e26926. doi:10.7759/cureus.26926
Graves S, Sullivan M, Adkoli A, Zhou Q, Chi D, Ellenson L, Cearbhaill R, Weigelt B, Grisham R. Progression-free and Overall Survival among newly diagnosed HRD-positive ovarian cancer without a BRCA mutation. Oral plenary at Society of Gynecology Oncology (SGO) Annual Meeting 2023. March 2023. San Diego, CA.
Adkoli A, Eng S, Stephenson R. Need For Formalized Robotic Training and Curriculum in Obstetrics and Gynecology Residency: An Examination of Current Resident Outlooks and Perspectives. Poster Presented at AMEE 2024 The Internal Associated for Health Professions Education. August 10th. Virtual. Basel, Switzerland.
Hollingsworth J, Wu S, Adkoli A, Farrell A, Hodges K, Oberley M, Karnezis A, Thaker P, Girda E. Molecular characterization of squamous cell ovarian cancers for identification of therapeutic targets. Poster presented at Society of Gynecologic Oncology (SGO) Annual Conference 2024. March 17th 2024. San Diego, CA.
Sullivan M, Graves S, Adkoli A, Zhou Q, Iasonos A, Ellenson L, Chi D, O’Cearbhaill, Weigelt B, Grisham R. Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer. Poster presented at Society of Gynecologic Oncology (SGO) Annual Conference 2024. March 17th 2024. San Diego, CA.
Gabriella Lobitz, Emily B Rosenfeld, Rachel Lee, Deepika Sagaram, Cande V Ananth. Risk of short-term cardiovascular disease in relation to the mode of delivery in singleton pregnancies: a retrospective cohort study, EClinicalMedicine, 2024 Sep 26:76:102851. PMID: 39391017.
Gabriella Lobitz, MD, Emily B. Rosenfeld, DO, Rachel Lee, MS, Deepika Sagaram, MD, Cande V. Ananth, PhD, MPH. The risk of mortality from cardiovascular disease differs depending on the mode of delivery. Poster Presentation. SMFM The Pregnancy Meeting, National Harbour, MD, February 2024.
Gabriella Lobitz, MD, Emily B. Rosenfeld, DO, Rachel Lee, MS, Deepika Sagaram, MD, Cande V. Ananth, PhD, MPH. Mode of Delivery Affects Short-Term Risk of Cardiovascular Mortality and Morbidity. Oral Presentation. SMFM The Pregnancy Meeting, National Harbour, MD, February 2024.
Gabriella Lobitz, Emily B. Rosenfeld, Shama P. Khan, Todd Rosen, Elena Ashkinadze. Comparing the yield of meaningful findings in targeted versus genome-wide cell free DNA screening. Poster Presentation. SMFM The Pregnancy Meeting, National Harbour, MD, February 2024.
Gabriella Lobitz, MD, Emily B. Rosenfeld, DO, Rachel Lee, MS, Deepika Sagaram, MD, Cande V. Ananth, PhD, MPH. Mode of delivery does not impact cardiovascular morbidity in patients with prior cardiovascular disease. Poster presentation. SMFM The Pregnancy Meeting, National Harbour, MD, February 2024.
Mehta V, Hollingsworth J, Bordogna A, Pruitt-Smith T, Aikins J, Ayers C. Addressing cervical cancer screening disparities in Ghana through community outreach and collaborative training. Presented at: Robert Wood Johnson Global Health Fair; December 2024; New Brunswick, NJ.
Mehta, V., & Ebert, G. A. (2024). Sexually transmitted infections. In Customized Ob/Gyn Management for Diverse Populations (pp. 205–216). Elsevier. https://doi.org/10.1016/B978-0- 323-90263-2.00012-4
Shah N, Bayat L, Girda E. Atypical (Non-Target) Embolization following Preoperative Uterine Artery Embolization for Gravid Hysterectomy. Oral Presentation. 5/17/24, ACOG Annual Clinical & Scientific Meeting 2024. San Francisco, CA
Yamada, R., Sachdev, D., Lee, R., Sauer, M.V., & Ananth, C.V. Infertility treatment is associated with increased risk of postpartum hospitalization due to heart disease. Journal of Internal Medicine. 2024, Feb; 295(5):668-678. PMID: 38403886.
Yamada, R., Rosenbaum, C., Park, S.U., Li, H.J., & DeCherney, A.H. Career outcomes of obstetrics and gynecology residents who complete an away elective in reproductive endocrinology and infertility. Oral presentation, American Society of Reproductive Medicine Annual Meeting. 2024, Oct. Denver, CO, USA.
Yamada, R., Genovese, H.G., Willson, S.F., Whitehead, C.V., Drews, M.R., & Werner, M.D. Optimizing the modified natural frozen embryo transfer protocol: Should we wait for an endogenous luteinizing hormone surge? Poster presentation, Pacific Coast Reproductive Society Annual Meeting. 2024, Mar. Indian Wells, CA, USA.
Yamada, R., Park, S.U., & Matthews, G.A. Caring for Gender and Sexually Diverse Populations: LGBTQIA+ Patients. In G.A. Bachmann & J.A. Hutchinson-Colas (Ed.), Customized Ob/Gyn Management for Diverse Populations, pp 163-169. 2024, Oct. Cambridge: Academic Press.
Zhang, J. T., Lee, R., Sauer, M. V., Ananth, C. V. Risks of placental abruption and preterm delivery in patients undergoing assisted reproduction. Jama Network Open. 2024; 7(7):e2420970.
Zhang, J. T., Gelman, B., Sauer, M. V., Ananth, C. V. Increased stillbirth risk in women undergoing infertility treatment and ART; a population-based cross-sectional study in the United States, 2016-2023. Oral Presentation, American Society for Reproductive Medicine Annual Meeting. San Antonio, TX. October 28, 2025.
Zhang, J. T., Gill, P., Whitehead, C., Werner, M., Bergh, P. The presence of a chorionic bump in the first trimester is associated with an increased risk of clinical loss among patients undergoing in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing for aneuploidy (PGT-A). Poster Presentation, Pacific Coast Reproductive Society. Indian Wells, CA. March 21, 2024.